COMP <GO>
OSUR vs UTMD // RETURN ON INVESTED CAPITAL (ROIC)
OraSure Technologies Inc. (NASDAQ) VS. Utah Medical Products Inc. (NASDAQ) • 15-METRIC TALLY: OSUR 2
— UTMD 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: UTMD
LAST: $3.46 (-12.31%) • MKT CAP: $271.7M
roic
-35.00%
LAST: $70.55 (+3.64%) • MKT CAP: $216.7M
roic
26.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSUR VS. UTMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OSUR | UTMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.90% | 57.10% | -15.20 | UTMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 26.90% | -61.90 | UTMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 10.8x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -18.91% | 6.73% | -25.64 | UTMD | /fcf-yield <GO> |
| Operating Margin | -60.00% | 29.60% | -89.60 | UTMD | /operating-margins <GO> |
| Net Profit Margin | -59.80% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -38.10% | -5.80% | -32.30 | UTMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.87% | -1.87 | UTMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.47 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | UTMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.3 | 34.2 | +17.10 | OSUR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $271.7M | $216.7M | $55.0M | OSUR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OSUR REV | UTMD REV | OSUR GROSS % | UTMD GROSS % | OSUR FCF | UTMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $115.0M | $38.5M | 41.9% | 57.1% | -$53.2M | $14.3M |
| FY 2024 | $185.8M | $40.9M | 42.7% | 59.0% | $23.6M | $14.6M |
| FY 2023 | $405.5M | $50.2M | — | — | $141.6M | $22.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSUR // BETA —
UTMD // BETA —